The US Food and Drug Administration (FDA) has approved the Abbott Proclaim XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN), a debilitating complication of diabetes. The Proclaim XR SCS system can provide relief to DPN...
Erchonia has received 510(k) clearance from the US Food and Drug Administration for its low level laser technology to treat whole-body postoperative pain. The company’s latest 510(k) statement from the U.S. FDA is based on level 1 blinded and controlled clinical...
Koya Medical has received Food and Drug Administration (FDA) 510(k) clearance for its Dayspring Lite treatment for lymphedema and venous disease, it announces. Unlike traditional compression pumps that require patients to be tethered to the wall during use, the...
Abbott has received approval from the US Food and Drug Administration (FDA) for the use of the company’s Patient Controller app on compatible personal Apple smartphone devices, it announces. This app approval gives patients living with neurological conditions,...
Erchonia Corporation announces that the US Food and Drug Administration (FDA) has granted the company 510(k) clearance to market its FX 635 low-level laser for the temporary relief of chronic, nociceptive musculoskeletal pain. Erchonia received FDA clearance...
